Details of the Drug

General Information of Drug (ID: DMO7PBU)

Drug Name
NGM217
Indication
Disease Entry ICD 11 Status REF
Type 2 diabetes 5A11 Phase 1 [1]
Cross-matching ID
TTD ID
D3NB8K

References

1 Clinical pipeline report, company report or official report of NGM Biopharma